25
Participants
Start Date
February 2, 2026
Primary Completion Date
February 2, 2028
Study Completion Date
December 31, 2028
Epidiolex 100 mg/mL Oral Solution
The participant's 'artisanal' CBD and Epidiolex dose should be taken consistently with food or consistently without food throughout the entire study. The participant's dosing with or without food should be consistent with their method of dosing of 'artisanal' CBD prior to screening. Oral administration is recommended. When necessary, Epidiolex can be enterally administered via silicone feeding tubes, such as nasogastric or gastrostomy tubes.
The Hospital for Sick Children, Toronto
Collaborators (1)
Jazz Pharmaceuticals
INDUSTRY
Alberta Children's Hospital
OTHER
BC Children's Hospital Research Institute
OTHER
Elizabeth Donner
OTHER